Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs




Leadership, Results Gets Madagascar $110 Million

Madagascar"I am a man of action," Madagascar's President Mark Ravalomana told his audience at the Johns Hopkins' School of Advanced International Studies today. Ravalomana was in Washington DC, for the signing of a $110 million poverty reduction compact between his country and the United States.

Malaria Trial Could Set a Model For Financing of Costly Vaccines

The Wall Street Journal has a front page article today about progress towards a Malaria Vaccine. (Subscription required.)

"Under two new funding strategies championed by Microsoft Corp. founder Bill Gates and Britain's finance minister, Gordon Brown, rich nations and their private-sector partners for the first time would jointly guarantee the provision of vaccines against the worst scourges afflicting the developing world.

Gordon Brown Says Growing Interest in Advance Market Commitments

Gordon BrownGordon Brown said on Monday that there is growing interest in advance purchase commitments to buy a malaria vaccine. The UK Finance Minister was speaking on the occasion of being awarded a Commitment to Development Award by the Center for Global Development and Foreign Policy Magazine.

AIDS Vaccine Trials a Success in India

According to Rediff, a new AIDS vaccine could be as little as 5 years away:

Upbeat at the successful completion of clinical trials of an HIV/AIDS vaccine on first 10 volunteers in Pune, the Indian Council of Medical Research on Wednesday said if things go right the antidote for the dreaded disease will be available in the market five years from now.

Balancing "Country Ownership" and MCA Priorities

Today Michael Phillips brought the MCA to the front page of the Wall Street Journal. His article was an in-depth look at the first MCA compact with Madagascar, and the national dynamics that ushered this particular compact into being. He opened the article from Antananarivo with this:

Combination Vaccine Produces Lower Immune Response

JAMA logoA combination vaccine developed to reduce the number of injections infants receive appears to provide less immunity than the vaccines administered individually, according to a study in the April 13 2005 issue of JAMA.

Jim P. Buttery and colleagues conducted a study to determine the immunogenicity and safety of a combination 9-valent pneumococcal-group C meningococcal conjugate candidate vaccine.